The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults

Coming Soon.

Year: 2022

Reference: Aljumaah, M. R., Bhatia, U., Roach, J., Gunstad, J., & Azcarate Peril, M. A. (2022). The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults. Clinical nutrition (Edinburgh, Scotland), 41(11), 2565–2576. https://doi.org/10.1016/j.clnu.2022.09.012

Related Studies

Microbial metabolites tune amygdala neuronal hyperexcitability and anxiety-linked behaviors

Alterations in gut microbiota composition have been associated with anxiety behaviors in rodents, but the neural mechanisms connecting microbiota and their metabolites to anxiety are not yet understood. The immediate early c-Fos gene expression in the basolateral amygdala (BLA) significantly increased in male C57BL/6J germ-free (GF) mice in this study by Yu et al. (2025), […]

From fork to feelings: How foods shape mental health via the microbiota–gut–brain axis

The microbiota–gut–brain axis represents a bidirectional communication system between the gut microbiota and the brain, facilitated by neural, metabolic, immune, and endocrine signals. This axis significantly influences mental health by regulating stress responses, mood, and cognitive functions, and its dysregulation is observed in various psychiatric disorders. While the gut microbiota remains relatively stable during healthy […]